Iron Storage within Dopamine Neurovesicles Revealed by Chemical Nano-Imaging
暂无分享,去创建一个
Peter Cloetens | Sylvain Bohic | Guillaume Devès | G. Deves | R. Ortega | P. Cloetens | S. Bohic | Richard Ortega | A. Carmona | Asunción Carmona | G. Devès
[1] R. Hider,et al. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy , 2005, British journal of pharmacology.
[2] J. Connor,et al. Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.
[3] Diana Suffern,et al. Photophysics of dopamine-modified quantum dots and effects on biological systems , 2006, Nature materials.
[4] P. Moretto,et al. Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells. , 1996, Cellular and molecular biology.
[5] P D Griffiths,et al. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.
[6] Anatoly Snigirev,et al. Synchrotron hard x-ray microprobe: Fluorescence imaging of single cells , 2001 .
[7] L. Greene,et al. Morphologic and cytochemical properties of a clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1978, Laboratory investigation; a journal of technical methods and pathology.
[8] Patrik Brundin,et al. Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein , 2002, Nature Reviews Neuroscience.
[9] A. Torp,et al. Fluorescence of catechol amines and related compounds condensed with formaldehyde , 1962, Brain Research Bulletin.
[10] J. Segura-Aguilar,et al. Dopamine-dependent iron toxicity in cells derived from rat hypothalamus. , 2005, Chemical Research in Toxicology.
[11] L. Greene,et al. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[12] C. Quintana,et al. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. , 2006, Journal of structural biology.
[13] A. Santagostino,et al. Mitochondrial toxicity of iron and the protective role of ferritin on dopaminergic PC12 cell line. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.
[14] G. Deves,et al. Microchemical element imaging of yeast and human cells using synchrotron X-ray microprobe with Kirkpatrick-Baez optics. , 2004, Analytical chemistry.
[15] Subramanian Rajagopalan,et al. Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.
[16] J. Smythies. The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: Functional interrelationships in health and disease: A review — discussion , 1999, Neurotoxicity Research.
[17] S. Lipton,et al. Molecular pathways to neurodegeneration , 2004, Nature Medicine.
[18] A. Graybiel,et al. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.
[19] V. M. Pickel,et al. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells , 1994, The Journal of cell biology.
[20] P. Cloetens,et al. Efficient sub 100 nm focusing of hard x rays , 2005 .
[21] V. A. Solé,et al. A multiplatform code for the analysis of energy-dispersive X-ray fluorescence spectra , 2007 .
[22] C. Marsden,et al. INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAIN , 1987, The Lancet.
[23] G. Thieme,et al. FLUORESCENCE OF CATECHOL AMINES AND RELATED COMPOUNDS CONDENSED WITH FORMALDEHYDE , 1962 .
[24] P. Kirkpatrick,et al. Formation of optical images by X-rays. , 1948, Journal of the Optical Society of America.
[25] M. Youdim,et al. Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats , 2004, Neuropharmacology.
[26] T. Rouault,et al. Iron on the brain , 2001, Nature Genetics.
[27] W. Linert,et al. Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's Disease. , 2000, Journal of inorganic biochemistry.
[28] K. Zierold,et al. The element distribution in ultrathin cryosections of cultivated fibroblast cells , 2004, Histochemistry.
[29] J. Dankert,et al. PENICILLIN-SENSITIVE STREPTOCOCCAL ENDOCARDITIS , 1982, The Lancet.
[30] A. Kakita,et al. Relationship Among &agr;-Synuclein Accumulation, Dopamine Synthesis, and Neurodegeneration in Parkinson Disease Substantia Nigra , 2006, Journal of neuropathology and experimental neurology.
[31] Y. Agid,et al. Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease , 1993, Brain Research.
[32] Peter Riederer,et al. Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.
[33] H. Lashuel,et al. Rescuing defective vesicular trafficking protects against alpha-synuclein toxicity in cellular and animal models of Parkinson's disease. , 2006, ACS chemical biology.
[34] D. Eide. Zinc transporters and the cellular trafficking of zinc. , 2006, Biochimica et biophysica acta.
[35] Ya Ke,et al. Iron misregulation in the brain: a primary cause of neurodegenerative disorders , 2003, The Lancet Neurology.
[36] D. Smith,et al. Manganese oxidation state mediates toxicity in PC12 cells. , 2005, Toxicology and applied pharmacology.
[37] Sriram Subramaniam,et al. Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism. , 2005, Journal of structural biology.